Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2000
03/23/2000WO2000015784A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
03/23/2000WO2000015783A2 ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO β1-ADRENOCEPTOR-SPECIFIC mRNA AND METHODS OF USE
03/23/2000WO2000015781A1 Antagonists of fibroblast growth factor
03/23/2000WO2000015774A1 Useful properties of a bee venom protein and gene encoding same
03/23/2000WO2000015773A2 Inhibition of oncogene transcription by synthetic polyamides
03/23/2000WO2000015770A2 Human serine/threonine protein kinases
03/23/2000WO2000015769A1 Topa
03/23/2000WO2000015767A2 Antigen-presenting cells and their use in therapy
03/23/2000WO2000015759A1 Interleukin 17-like receptor protein
03/23/2000WO2000015665A2 A method of producing a functional immunoglobulin superfamily protein
03/23/2000WO2000015664A1 Modified human growth hormone
03/23/2000WO2000015663A1 MIP-1α ISOFORM LD78β AND USES THEREOF
03/23/2000WO2000015660A1 Target of rnaiii activating protein (trap)
03/23/2000WO2000015659A2 Stomach polypeptide zsig28
03/23/2000WO2000015658A1 FACTOR VIIa INHIBITORS
03/23/2000WO2000015657A1 Piperizine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and 53
03/23/2000WO2000015655A1 Process for producing peptides from biological fluids and peptides obtainable by said process
03/23/2000WO2000015654A1 Cyclised conotoxin peptides
03/23/2000WO2000015651A1 Regulation of immune responses by attractin
03/23/2000WO2000015649A1 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130
03/23/2000WO2000015273A1 Biologically active implants
03/23/2000WO2000015264A1 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression
03/23/2000WO2000015263A1 Expandible microparticle intracellular delivery system
03/23/2000WO2000015259A1 Antibodies to c3b(i) for delivery of diagnostic and therapeutic agents to cancer cells
03/23/2000WO2000015252A1 Method of using zot or zonulin to inhibit lymphocyte proliferation in an antigen-specific manner
03/23/2000WO2000015250A2 Fibroblast inhibitor
03/23/2000WO2000015249A1 Treatment of kaposi's sarcoma with il-12
03/23/2000WO2000015248A2 Growth factor-containing composition for healing tissue damage
03/23/2000WO2000015247A2 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
03/23/2000WO2000015246A2 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
03/23/2000WO2000015245A2 Stable liquid formulations of botulinum toxin
03/23/2000WO2000015244A2 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor
03/23/2000WO2000015243A1 A method of treatment and agents useful for same
03/23/2000WO2000015242A1 REGULATION OF HER2/neu ONCOGENE EXPRESSION BY SYNTHETIC POLYAMIDES
03/23/2000WO2000015230A1 METHOD FOR TREATING ATHEROSCLEROSIS EMPLOYING AN aP2 INHIBITOR AND COMBINATION
03/23/2000WO2000015229A1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND COMBINATION
03/23/2000WO2000015228A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents
03/23/2000WO2000015224A1 Protein formulations
03/23/2000WO2000015214A1 Fc RECEPTOR MODULATORS AND USES THEREOF
03/23/2000WO2000015210A2 Use of mycophenol acid and its derivatives for the treatment of virus diseases
03/23/2000WO2000015209A2 REGULATION OF HER2/neu ONCONGENE EXPRESSION BY SYNTHETIC POLYAMIDES
03/23/2000WO2000015208A2 New use of immunosupressants for mmp-mediated diseases
03/23/2000WO2000015188A1 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution)
03/23/2000WO2000015175A2 Use as an active substance of molecules binding to beta-1-integrin with the capacity to kill cells
03/23/2000WO2000015167A1 Anti-inflammatory and antimicrobial uses for bioactive glass compositions
03/23/2000WO2000006134A3 Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
03/23/2000WO2000004153A3 Repression of cell transformation with human pea3
03/23/2000WO2000000599A3 Composition for the induction of apoptosis in target cells
03/23/2000WO1999067268A9 Diacylglycerol o-acyltransferase
03/23/2000WO1999066948A3 Use of a dipeptide for stimulating repair processes
03/23/2000WO1999064057A9 Retinoic acid inducible dna sequences from lung cells
03/23/2000WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
03/23/2000WO1999062938A3 Polypeptides, traditionally of the human herpes virus type 8 and the diagnostic and medical application thereof
03/23/2000WO1999062931A3 A cell density signal protein suitable for treatment of connective tissue injuries and defects
03/23/2000WO1999061607A3 Antisense oligonucleotides for treating proliferating cells
03/23/2000WO1999061085A3 Method and compositions for treatment of cancers
03/23/2000WO1999060115A3 Proteins and genes useful as tumor markers
03/23/2000WO1999058650A9 Lytic enzymes useful for treating fungal infections
03/23/2000WO1999055876A3 Polypeptide with immunogenic properties and with a protein with modified biological functions
03/23/2000WO1999054473A3 Bacterial yjeq polypeptide family
03/23/2000WO1999053061A3 Tumor associated nucleic acids and uses therefor
03/23/2000WO1996040039A3 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
03/23/2000DE19846979A1 New human and murine G-coupled receptor EDG (endothelial differentiation gene) 6, useful for modulating inflammatory and immune reactions and for treatment of allergy or tumors
03/23/2000DE19842415A1 Pharmaceutical preparation for treating e.g. tumors, thrombosis or inflammation, contains cyclic pentapeptide integrin inhibitor and chemotherapeutic agent and/or angiogenesis inhibitor
03/23/2000DE19816732A1 Diagnostik und Therapie von Erkrankungen im Zusammenhang mit HHV-8-Infektionen Diagnosis and treatment of diseases associated with HHV-8 infection
03/23/2000CA2706859A1 Mammalian transforming growth factor beta - 9
03/23/2000CA2346262A1 Methods for treatment of degenerative retinal diseases
03/23/2000CA2344654A1 Regulation of her2/neu oncogene expression by synthetic polyamines
03/23/2000CA2344441A1 Expandible microparticle intracellular delivery system
03/23/2000CA2344309A1 Method for treating diabetes employing an ap2 inhibitor and combination
03/23/2000CA2344300A1 Method for treating atherosclerosis employing an ap2 inhibitor and combination
03/23/2000CA2344151A1 Pharmaceutical preparation
03/23/2000CA2344048A1 Factor viia inhibitors
03/23/2000CA2343838A1 Atp synthase subunit homolog
03/23/2000CA2343654A1 Method for down-regulating osteoprotegerin ligand activity
03/23/2000CA2343578A1 Human serine/threonine protein kinases
03/23/2000CA2343574A1 Metabotropic gaba receptor complex issued from the central nervous system
03/23/2000CA2343355A1 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression
03/23/2000CA2343352A1 A method of treatment and agents useful for same
03/23/2000CA2343313A1 A method of producing a functional immunoglobulin superfamily protein
03/23/2000CA2343268A1 Protein formulations
03/23/2000CA2343223A1 Anti-inflammatory and antimicrobial uses for bioactive glass compositions
03/23/2000CA2343006A1 Compositions and methods for the treatment of immune related diseases
03/23/2000CA2343001A1 Stomach polypeptide zsig28
03/23/2000CA2342965A1 Leptin induced genes
03/23/2000CA2342958A1 Rna-associated proteins
03/23/2000CA2342833A1 Human gpcr proteins
03/23/2000CA2342771A1 Method of using zot or zonulin to inhibit lymphocyte proliferation in an antigen-specific manner
03/23/2000CA2342601A1 Antibodies to c3b(i) for delivery of diagnostic and therapeutic agents to cancer cells
03/23/2000CA2342398A1 Moraxella catarrhalis basb034 polypeptides and uses thereof
03/23/2000CA2342395A1 Process for producing peptides from biological fluids and peptides obtainable by said process
03/23/2000CA2342301A1 Human cell junction pdz protein
03/23/2000CA2342278A1 Inhibition of oncogene transcription by synthetic polyamides
03/23/2000CA2342243A1 Stable liquid formulations of botulinum toxin
03/23/2000CA2341767A1 Promotion or inhibition of angiogenesis and cardiovascularization
03/23/2000CA2341683A1 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
03/23/2000CA2341155A1 Genes encoding for the human and murine death inducer-obliterator-1
03/22/2000EP0987917A1 Method of cell data transmission, cell, communication system and corresponding network terminal unit
03/22/2000EP0987552A2 Diarylsulfonylurea binding proteins
03/22/2000EP0987329A2 Multimeric form of human rhinovirus receptor protein
1 ... 2410 2411 2412 2413 2414 2415 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 2426 2427 2428 2429 2430 ... 3163